Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tandem Diabetes Care (TNDM)
NASDAQ:TNDM
Holding TNDM?
Track your performance easily
TNDM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$13.82 - $53.69
Previous Close$44.63
Volume1.85M
Average Volume (3M)1.56M
Market Cap
$2.92B
Enterprise Value$2.95B
Total Cash (Recent Filing)$452.42M
Total Debt (Recent Filing)$477.11M
Price to Earnings (P/E)―
Beta1.90
Next Earnings
Oct 30, 2024EPS Estimate
-$0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.09
Shares Outstanding65,464,900
10 Day Avg. Volume1,048,243
30 Day Avg. Volume1,563,711
Standard Deviation0.18
R-Squared0.15
Alpha-0.00898
Financial Highlights & Ratios
Price to Book (P/B)12.50
Price to Sales (P/S)3.67
Price to Cash Flow (P/CF)-138.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.70
Enterprise Value/Gross Profit8.01
Enterprise Value/Ebitda-50.70
Forecast
1Y Price Target
$55.85Price Target Upside25.14% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
Tandem Diabetes Care News
Bulls Say, Bears Say
Bulls Say
Market PenetrationTNDM is now forecasting that penetration could step up dramatically to around 25% levels among the US Type 2 diabetes population within a few years, versus closer to 5% today.
Product FeedbackManagement highlighted that in pre-market testing, patient satisfaction with Mobi was nearly 90% owing mainly to its small size and that a top area of customer feedback continues to be a positive surprise at how light the device is.
Revenue GrowthShares likely trade higher on 2Q revenue upside and full-year guidance raise as early Mobi uptake is helping reverse sizable pump volume and revenue pressures from the previous year.
Bears Say
Commercial ExecutionA supply shortage of this magnitude so early on in the launch could raise concerns on TNDM's commercial execution.
Competitive PressuresThe competitive environment for TNDM is also harsher than it was a few years ago, with MDT's 780G, Beta Bionics' iLet, and PODD's O5 all strong competitors.
Supply ShortageA Mobi shortage could potentially weigh on TNDM's U.S. pump sales and create risk for 2Q estimates, especially if it lasted an entire month or more.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TNDM FAQ
What was Tandem Diabetes Care’s price range in the past 12 months?
Tandem Diabetes Care lowest stock price was $13.82 and its highest was $53.69 in the past 12 months.
What is Tandem Diabetes Care’s market cap?
Currently, no data Available
When is Tandem Diabetes Care’s upcoming earnings report date?
Tandem Diabetes Care’s upcoming earnings report date is Oct 30, 2024 which is in 36 days.
How were Tandem Diabetes Care’s earnings last quarter?
Tandem Diabetes Care released its earnings results on Aug 01, 2024. The company reported -$0.47 earnings per share for the quarter, beating the consensus estimate of -$0.542 by $0.072.
Is Tandem Diabetes Care overvalued?
According to Wall Street analysts Tandem Diabetes Care’s price is currently Undervalued.
Does Tandem Diabetes Care pay dividends?
Tandem Diabetes Care does not currently pay dividends.
What is Tandem Diabetes Care’s EPS estimate?
Tandem Diabetes Care’s EPS estimate is -$0.41.
How many shares outstanding does Tandem Diabetes Care have?
Tandem Diabetes Care has 65,464,900 shares outstanding.
What happened to Tandem Diabetes Care’s price movement after its last earnings report?
Tandem Diabetes Care reported an EPS of -$0.47 in its last earnings report, beating expectations of -$0.542. Following the earnings report the stock price went up 18.347%.
Which hedge fund is a major shareholder of Tandem Diabetes Care?
Among the largest hedge funds holding Tandem Diabetes Care’s share is Gilder Gagnon Howe & Co LLC.. It holds Tandem Diabetes Care’s shares valued at 41M.
---
Tandem Diabetes Care Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$55.85 (25.14% Upside)
$55.85 (25.14% Upside)
Blogger Sentiment
Bullish
TNDM Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 269.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.3%
Last 30 Days <0.1%
Last 30 Days <0.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
96.00%
12-Months-Change
Fundamentals
Return on Equity
-48.48%
Trailing 12-Months
Asset Growth
-0.97%
Trailing 12-Months
Company Description
Tandem Diabetes Care
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.
---
TNDM Company Deck
---
TNDM Earnings Call
Q2 2024
0:00 / 0:00
---
TNDM Revenue Breakdown
74.21% U.S.
25.79% International
---
TNDM Stock 12 Month Forecast
Average Price Target
$55.85
▲(25.14% Upside)
Technical Analysis
Best Analysts Covering TNDM
1 Year
1 Year Success Rate
22/28 ratings generated profit
1 Year Average Return
+126.34%
reiterated a buy rating 2 months ago
Copying Steven Lichtman's trades and holding each position for 1 Year would result in 78.57% of your transactions generating a profit, with an average return of +126.34% per trade.
---